Next-Generation pan-cancer blood proteome profiling

In this white paper, you will discover how characterization of 1,463 proteins from more than 1,400 patients representing 12 types of cancer at time of diagnosis and before treatment, enabled the identification of a panel of 83 proteins that can identify and discriminate between all of the individual cancer types with high accuracy.

Learn more about how Olink® solutions for high-throughput proteomics can accelerate oncology research and drive new therapies

Access interactive functions* to explore this unique dataset, including differential expression analysis, pathway enrichment, pathway annotation with hexagonal maps, and predictive protein groups identified by machine learning.

Learn how Olink’s solutions for protein biomarker discovery are being applied in this critical and rapidly developing field, providing non-invasive insights into what is happening in the tumor microenvironment to monitor and predict treatment responses.

Measure the concentration of thousands of human plasma proteins using minute amounts of sample with our high-throughput protein biomarker discovery platform based on Olink’s Proximity Extension Assay (PEA) technology coupled with NGS readout on Illumina instruments.

Do you need more information on our solutions for protein biomarker discovery or wish to discuss how we can help with your proteomic study?
Let us know using this form!


Biomarker assays

~881 million

Protein data points generated


Publications listed on website